Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Tomosynthesis guided biopsy

BGICC 2023

19 - 20 Jan 2023

Published: 3 Feb 2023

Views: 11

Rating:

Save

Prof Shilpa Lad - NM Medical Centre, Mumbai, India

Prof Shilpa Lad speaks to ecancer about tomosynthesis guided biopsy.

She explains the difference between 2D and 3D tomosynthesis. With the advent of 3D tomosynthesis, there is now an ability to carry out biopsies with 3D tomosynthesis.

She further explains how to carry out a 3D tomosynthesis-guided biopsy and why early training of radiologists is important.

Related Videos

Digital rectal examination is not useful as a solitary screening tool for...

Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )

Global adoption of single-shot targeted IORT for breast cancer

Dr Jayant Vaidya - University College London, London, UK

Global adoption of single-shot targeted IORT for breast cancer ( Dr Jayant Vaidya - University College London, London, UK )

IORT at the Asian Hospital and Medical Center

Dr Aldine Basa - Asian Hospital and Medical Center, Manila, Philippines

IORT at the Asian Hospital and Medical Center ( Dr Aldine Basa - Asian Hospital and Medical Center, Manila, Philippines )

Evidence-based approach to lymph node assessment and targeted axillary...

Prof Jessica Leung - MD Anderson Cancer Center, Houston, USA

Evidence-based approach to lymph node assessment and targeted axillary dissection ( Prof Jessica Leung - MD Anderson Cancer Center, Houston, USA )

Moving to the future: Artificial intelligence in surgery

Dr Maria João Cardoso - Champalimaud Cancer Centre, Lisbon, Portugal

Moving to the future: Artificial intelligence in surgery ( Dr Maria João Cardoso - Champalimaud Cancer Centre, Lisbon, Portugal )

Genetic profiling identifies patients who can omit radiation therapy after...

Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery ( Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden )

HER2DX confirms the ability of the test to predict long-term survival and...

Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain

HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC ( Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain )

Individualised breast cancer risk assessment model for BreastScreen Norway

Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain.

Individualised breast cancer risk assessment model for BreastScreen Norway ( Dr Javier Louro - Hospital del Mar Medical Research Institute, Barcelona, Spain. )

Optimum treatment strategy algorithm for mCRC

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Optimum treatment strategy algorithm for mCRC ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

More from ecancer